价格

重组人5型腺病毒

Recombinant Human Adenovirus

未知生产厂商

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

适应症

对常规放疗或放疗加化疗治疗无效，并以5-FU、顺铂化疗方案进行姑息治疗的晚期鼻咽癌患者可试用本品与前述化疗方案联合使用。

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Complementing cell lines
US 6974695 B2申请人: CRUCELL HOLLAND BV优先权: 2000
US
13 件公开
Packaging systems for human recombinant adenovirus to be used in gene therapy
- US 7105346 B2
  申请人: CRUCELL HOLLAND BV优先权: 2001
  US
  10 件公开
- US 7037716 B2
  申请人: CRUCELL HOLLAND BV优先权: 2001
  US
  3 件公开
- US 6602706 B1
  申请人: INTROGENE BV优先权: 2000
  US
  2 件公开
- US 2002187553 A1
  申请人: FALLAUX FRITS J优先权: 2001
  US
  2 件公开
Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein
US 11453704 B2申请人: ACAD OF MILITARY MEDICAL SCIENCE PLA优先权: 2018
CN
EP
US
WO
5 件公开
EXPRESSION VECTOR AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2
US 2022235376 A1申请人: FEDERAL STATE BUDGETARY INSTITUTION NATIONAL RES CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAME优先权: 2020
CN
EP
US
WO
4 件公开
PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2
US 2022226466 A1申请人: FEDERAL STATE BUDGETARY INSTITUTION NATIONAL RES CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAME优先权: 2020
CN
EP
US
WO
4 件公开
Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
US 9315827 B2申请人: BEIJING BIO TARGETING THERAPEUTICS TECHNOLOGY INC优先权: 2011
US
4 件公开
Rcombinant adenovirus and its use in preventing and treating fibrous diseases
CN 1307102 A申请人: BAIHUAN BIOLOG MEDICINE RES CT优先权: 2000
CN
US
2 件公开
Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases
US 2009215164 A1申请人: PENG ZHAOHUI优先权: 2003
CN
US
2 件公开
Recombinant adenovirus of coexpression human P53 gene and human cytokine gene and its preparation method and application
CN 1177042 C申请人: SHANGHAI HUAKANG BIOLOG TECHNO优先权: 2001
CN
2 件公开
Targetting high-expression recombinant adenovirus of human granulocyte-macrophage colony stimulating factor and its preparing process and usage
CN 1177053 C申请人: HUAKANG BIOTECHNOLOGY CO LTD S优先权: 2001
CN
2 件公开

药物

重组人5型腺病毒

适应症

专利

Packaging systems for human recombinant adenovirus to be used in gene therapy